Correlation Between Albemarle Corp and Crispr Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Albemarle Corp and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Albemarle Corp and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Albemarle Corp and Crispr Therapeutics AG, you can compare the effects of market volatilities on Albemarle Corp and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Albemarle Corp with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Albemarle Corp and Crispr Therapeutics.

Diversification Opportunities for Albemarle Corp and Crispr Therapeutics

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Albemarle and Crispr is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Albemarle Corp and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Albemarle Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Albemarle Corp are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Albemarle Corp i.e., Albemarle Corp and Crispr Therapeutics go up and down completely randomly.

Pair Corralation between Albemarle Corp and Crispr Therapeutics

Considering the 90-day investment horizon Albemarle Corp is expected to generate 0.77 times more return on investment than Crispr Therapeutics. However, Albemarle Corp is 1.3 times less risky than Crispr Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.03 per unit of risk. If you would invest  13,686  in Albemarle Corp on September 2, 2022 and sell it today you would earn a total of  13,843  from holding Albemarle Corp or generate 101.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Albemarle Corp  vs.  Crispr Therapeutics AG

 Performance (%) 
       Timeline  
Albemarle Corp 
Albemarle Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Albemarle Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain essential indicators, Albemarle Corp may actually be approaching a critical reversion point that can send shares even higher in January 2023.

Albemarle Price Channel

Crispr Therapeutics 
Crispr Performance
0 of 100
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

Crispr Price Channel

Albemarle Corp and Crispr Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Albemarle Corp and Crispr Therapeutics

The main advantage of trading using opposite Albemarle Corp and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Albemarle Corp position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.
Albemarle Corp vs. Walmart
Albemarle Corp vs. Coca-Cola Co
Albemarle Corp vs. JPMorgan Chase Co
Albemarle Corp vs. Meta Materials
The idea behind Albemarle Corp and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Crispr Therapeutics vs. HP Inc
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go